Chicago BioCapital Summit

Chicago BioCapital Summit 2024

 

Chicago BioCapital Summit 2024 Info


SPEAKERS:

Jim Audia, PhD, EVP Drug Development, Founding Scientist, FLARE Therapeutics

Martin Burke, PhD, May and Ving Lee Professor for Chemical Innovation, and Professor of Chemistry, University of Illinois Urbana-Champaign

Rima Chakrabarti, MD, Venture Partner, KdT

 

Mira Chaurushiya, MD, Managing Director, Westlake Village BioPartners

George Church, PhD, Robert Winthrop Professor of Genetics, Wyss Institute and Harvard Medical School; Serial Entrepreneur

John Conrad, President & CEO at Illinois Biotechnology Innovation Organization (iBio)

 

Chris Ghadban, MBA, MS, Investor, The Venture Collective

Karen Heidelberger,MBA Partner and Chief Partnerships Officer, Deerfield Management

Milind Kamkolkar, Venture Partner, RA Capital Management

 

Ted LOVE, MD, Chairman, BIO; CEO, Global Blood Therapeutics (Acquired in 2022 by Pfizer)

Matej Macak, PhD, Partner, McKinsey & Company / Quantum Black

Matt McMahon, PhD, Director, SEED, National Institutes of Health (NIH)

 

Chris O'Donnell, PhD, Partner, Pfizer Ventures

Shobha Parthasarathi, PhD, Founder and Principal, Intovis

Steven Paul, MD, Venture Partner, Third Rock Ventures; Former CEO, CSO, Karuna Therapeutics (Acquired in 2023 by BMS)

 

Michal Preminger, PhD, MBA, Regional Head, Johnson & Johnson Innovation, E. North America

Anya Scheiss, MBA, Managing Partner, J.P. Morgan Life Sciences Private Capital

Erandi de Silva, PhD, Partner, Drive Capital

 

Steven Squinto, PhD, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital

Tim Walbert, Former Chairman, President and Chief Executive Officer, Horizon Therapeutics; Sr. Advisor, Amgen

Dana Watt, Partner, Breakout Ventures

 

Renee Yao, BS, Ecosystem Business Development, Healthcare Life Sciences, NVIDIA


MODERATORS:

Paul Burton, JD, MBA, Managing Partner, 2Flo Ventures

Dimitra Georganopoulou, PhD, General Partner, Qral Ventures

Julia Monfrini-Peev, Partner, PACE Healthcare Capital

 

Saif Rathore, MD, PhD, Senior Advisor, McKinsey & Company

Ritu Shah, PMP, Managing Director, Portal Innovations, LLC

Jim Sullivan, PhD, Chief Executive Officer, Vanqua Bio-Venture Partner, Orbimed


 

For more information on how to register for the Chicago BioCapital Summit, please contact Eleonora Gatta ( eleonora.gatta [at] northwestern.edu )
 



PROGRAM:

Chicago BioCapital Summit 2024 Agenda

Pre-Summit Events Info:

Empowered Perspectives:
High Tea with Women Investors in Life Sciences
(invitation only) – 10am-12pm.

You are cordially invited to an exclusive High Tea event celebrating the exceptional women investors who are shaping the future of biotech. This gathering offers a unique opportunity to connect, share insights, and build a supportive community of like-minded women in the industry.

Join us for an elegant morning of inspiring conversations, exquisite teas, and delectable treats.


Portal Innovations Pitch Day (invitation only) – 12:30-5pm

The day before the Chicago BioCapital Summit, Portal Innovations is hosting a private pitch event highlighting promising Life Sciences startups from the Chicago region currently fundraising pre-seed through series A.


Exclusive Pre-Summit Reception at Portal Innovations (invitation only) – 5-6:30pm
We are delighted to invite you to an exclusive reception bringing together biotech investors and industry experts. This special event is designed to foster connections, share insights, and explore opportunities within the Chicago biotech hub.


University of Michigan Reception (invitation only) – 6-8:30pm
Networking, food and drinks with University of Michigan biotech & medtech startup leaders, investors, entrepreneurs, alumni in the industry. Biocapital Summit attendees interested in learning more about our startups are welcome to attend.


 

For more information on how to register for the above events, please contact Eleonora Gatta ( eleonora.gatta [at] northwestern.edu )
 


SUMMIT AGENDA:


▸ Download Summit Program here (pdf)

8:00 – 8:30 AM Registration: Attendee arrival and check-in / Breakfast & Refreshments
8:30 – 8:40 AM Welcoming Remarks by Michelle Hoffmann, PhD, CBC Executive Director
8:40 – 9:10 AM Featured Guests (Fireside Chat):
Introduction by: Jim Sullivan PhD, Chief Executive Officer, Vanqua Bio-Venture Partner, Orbimed

  • Steven Paul, MD, Venture Partner, Third Rock Ventures; Founder and Board Chair, Seaport Therapeutics;
    Former CEO, CSO and President of R&D, Karuna Therapeutics
  • Jim Audia, PhD, EVP Drug Discovery & Early Development, Founding Scientist, FLARE Therapeutics
9:10 – 9:15 AM Remarks:

  • John Conrad, President & CEO, Illinois Biotechnology Innovation Organization (iBio)
9:15 – 9:45 AM Keynote Speaker:
Introduction by: Paul Burton, JD, MBA, Managing Partner, 2Flo Ventures

  • Ted Love, MD, Chairman, Biotechnology Innovation Organization (BIO); Former President and CEO, Global Blood Therapeutics
9:45 – 10:15 AM Distinguished Speaker (virtual)
Introduction by: Dimitra Georganopoulou, PhD, General Partner, Qral Ventures

  • George Church, PhD, Robert Winthrop Professor of Genetics, Harvard Medical School, co-founder of 50+ companies
10:15 – 10:45 AM Coffee Break
10:45 – 11:45 AM Panel 1: Attracting capital to emerging biotech hubs
Moderator: Julia Monfrini Peev, MS, Managing Partner, PACE Healthcare Capital Speakers:

  • Tim Walbert, Former Chairman, President and Chief Executive Officer, Horizon Therapeutics; Sr. Advisor, Amgen
  • Michal Preminger, PhD, MBA, Regional Head, Johnson & Johnson Innovation, E. North America
  • Stephen Squinto, PhD, CIO, J.P. Morgan Life Sciences Private Capital
  • Dana Watt, PhD, Partner, Breakout Ventures
  • Martin Burke, MD, PhD, May and Ving Lee Professor for Chemical Innovation, and Professor of Chemistry
11:45 – 11:50 AM Introduction to Hall of Inventions

  • Michelle Hoffmann, PhD, CBC Executive Director
11:50 – 2:50 PM Lunch

Hall of Inventions and sponsors talk

  • Hall of Inventions companies
  • CDD Vault introduction
2:50 – 3:20 PM Fireside Chat: Startup to Growth and Acquisition: A Founder’s Perspective

  • Shobha Parthasarathi, PhD, Founder and President, Intovis
  • Erandi de Silva, PhD, Partner, Drive Capital
3:20 – 4:20 PM Panel 2: Connecting the dots: aligning academic discoveries with investors and advisors
Moderator: Ritu Shah, Managing Director, Portal InnovationsSpeakers:

  • Karen Heidelberger, MBA, Partner and Chief Partnerships Officer, Deerfield Management
  • Rima Chakrabarti, MD, Venture Partner, KdT
  • Anya Schiess, MBA, Co-Managing Partner, J.P. Morgan Life Sciences Private Capital
  • Chris O’Donnell, PhD, Executive Director, WRDM; Partner, Pfizer Ventures
  • Mira Chaurushiya, PhD, Managing Director, Westlake Village BioPartners
  • Matthew McMahon, PhD, Director, SEED, NIH
4:20 – 4:45 PM Coffee Break
4:45 – 5:45 PM Panel 3: AI in the Life Sciences: Promise and Pitfalls
Moderator: Saif Rathore, MD, PhD Senior Advisor, McKinsey & CompanySpeakers:

  • Matej Macak, PhD, Partner, McKinsey Quantum Black
  • Milind Kamkolkar, MS, Partner, RA Capital
  • Renee Yao, BS, Ecosystem Business Development, Healthcare Life Sciences, NVIDIA
  • Chris Ghadban, MBA, MS, Investor, The Venture Collective
5:45 – 5:55 PM Closing Remarks
5:55 – 7:30 PM Reception at Portal Innovations

 

For more information on how to register for the Chicago BioCapital Summit, please contact Eleonora Gatta ( eleonora.gatta [at] northwestern.edu )
 


THANK YOU TO OUR SUPPORTING PARTNERS:

BioCentury

Portal Innovations

Phase Capital


1bio

Banc of California


THANK YOU TO OUR SPONSORS:
Croke Fairchild Duarte & Beres


Trammell Crow Company

CDD Vault


ESG=

J.P. Morgan=

Prendio-BioProcure=


Power Construction

ISEC


Amgen

Chan Zuckerberg Biohub Chicago

InteliSpark


Deloitte

Xentria

Cytiva


Lonza

Hollister Incorporated

Walder Ventures

Sheer Velocity


back to top